Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 92 of 95, showing 5 Applications out of 471 total, starting on record 456, ending on 460

# Protocol No Study Title Investigator(s) & Site(s)

456.

ECCT/24/04/03   SMAART-MAP trial
    Severe Malaria A Research and Trials consortium - Multisite Adaptive Platform trial   
Principal Investigator(s)
1. Prof Kathryn Maitland Maitland
Site(s) in Kenya
Kilifi County Hospital
 
View

457.

ECCT/24/04/04   TNBC
    A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY OF TOBEMSTOMIG/RO7247669 COMBINED WITH NAB-PACLITAXEL COMPARED WITH   PEMBROLIZUMAB COMBINED WITH NABPACLITAXEL IN PARTICIPANTS WITH PREVIOUSLY UNTREATED, PD-L1-POSITIVE, LOCALLY-ADVANCED UNRESECTABLE OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER   
Principal Investigator(s)
1. Mansoor Saleh
Site(s) in Kenya
1. University of Nairobi - Institute of Tropical and Infectious Diseases (Nairobi City county)
2. International Cancer Institute (Nandi county)
3. The Aga Khan University Hospital - Kenya (Nairobi City county)
 
View

458.

ECCT/24/04/05   Phase III Vitiligo Study
                                                                             A Double-Arm, Open Label, Phase III Study to Compare the                                           Efficacy and Safety of SCENESSE® and Narrow-Band Ultraviolet B (NB-UVB) Light versus NB-                                                                                    UVB Light Alone in the Treatment of Vitiligo   
Principal Investigator(s)
1. Dr. Hannah Wanyika Wanyika
Site(s) in Kenya
Kenyatta National Hospital -
 
View

459.

ECCT/24/04/07   FORMATIVE-PEARLS TRIAL
    PEARLS FORMATIVE  (Preventing pre-eclampsia: Evaluating AspiRin Low-dose regimens following risk Screening)    
Principal Investigator(s)
1. Zahida Qureshi
2. Alfred Osoti
3. George Gwako
4. Rosa Chemwey
Site(s) in Kenya
1. Kakamega General County Teaching and Referral Hospital (Kakamega county)
2. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
3. Kiambu Level 5 Hospital (Kiambu county)
4. Kisii Teaching and Referral Hospital (Kisii county)
5. Meru Teaching and Referral Hospital (Meru county)
 
View

460.

ECCT/24/04/08   Gates MRI TBV02-301
    A Phase 3, randomized, double-blind, placebo-controlled, multicenter, clinical trial to assess the prophylactic efficacy, safety, and immunogenicity of the investigational M72/AS01E-4 Mycobacterium tuberculosis (Mtb) vaccine when administered intramuscularly on a 0,1-month schedule to adolescents and adults.   
Principal Investigator(s)
1. Wilson Muraya
Site(s) in Kenya
1. KEMRI Mtwapa Clinical Research Site- Kilifi (Kilifi county)
 
View